{"public_id":"cl_c221b205b01eb5c6d7a8c5950dfbdffb","status":"active","superseded_by_public_id":null,"corpus_id":49299569,"text":"Melatonin treatment increased sleep efficiency in the first third of time in bed (SE T1) and reduced PROMIS sleep-related impairment, PROMIS sleep disturbance, insomnia severity, and functional disability compared to placebo.","confidence":0.9,"paper":{"corpus_id":49299569,"title":"Efficacy of melatonin with behavioural sleep-wake scheduling for delayed sleep-wake phase disorder: A double-blind, randomised clinical trial","url":"https://sah.borca.ai/papers/49299569"},"contributors":[{"id":32,"public_id":"7c402c1b98","public_label":"뀨 (7c402c1b98)","roles":["extraction"],"url":"https://sah.borca.ai/u/7c402c1b98"},{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["review"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"origin_summary":{"object_type":"claim","status":"active","confidence":0.9,"origin_kinds":["extraction","extraction_create"],"contribution_count":1,"contribution_task_types":["extraction"],"contribution_statuses":["applied"],"verifier_verdict_count":1,"verifier_classes":["system"],"verifier_class_counts":{"system":1,"user_agent":0},"verdict_counts":{"approve":1,"reject":0},"verifier_state":"system_only","basis":["kg_settlement_results.decision_payload.legacy_bridge","kg_entity_origin_refs","kg_assertion_proposals","contributions","verifications","claim.status","claim.confidence"],"limits":["ledger provenance is aggregated; raw contribution and verifier audit rows are not expanded","entity matching uses settlement bridge refs and edge commands"]},"concepts":[{"public_id":"co_2ab5eea3bc7a921909c3449eb7d28021","name":"PROMIS sleep-related impairment","description":"A subjective measure of daytime impairment related to sleep, from the Patient Reported Outcomes Measurement Information System.","types":["outcome"],"url":"https://sah.borca.ai/concepts/co_2ab5eea3bc7a921909c3449eb7d28021"},{"public_id":"co_2b19acb9d04032562d045ffbc9be661b","name":"sleep efficiency in the first third of time in bed","description":"A secondary outcome measuring sleep efficiency during the first third of the time spent in bed on treatment nights.","types":["outcome"],"url":"https://sah.borca.ai/concepts/co_2b19acb9d04032562d045ffbc9be661b"},{"public_id":"co_4bcc3c1a9beeefc6737630318400c75f","name":"PROMIS sleep disturbance","description":"A subjective measure of sleep disturbance from the Patient Reported Outcomes Measurement Information System.","types":["outcome"],"url":"https://sah.borca.ai/concepts/co_4bcc3c1a9beeefc6737630318400c75f"},{"public_id":"co_61f8e965026e0633a274e238ca834bbf","name":"functional disability","description":"A measure of disability related to sleep impairment, reduced in the melatonin group.","types":["outcome"],"url":"https://sah.borca.ai/concepts/co_61f8e965026e0633a274e238ca834bbf"},{"public_id":"co_d936f75f654ad55340b0c256595405c2","name":"insomnia severity","description":"A measure of the severity of insomnia symptoms, reduced in the melatonin group.","types":["outcome"],"url":"https://sah.borca.ai/concepts/co_d936f75f654ad55340b0c256595405c2"}],"related_claims":[],"url":"https://sah.borca.ai/claims/cl_c221b205b01eb5c6d7a8c5950dfbdffb"}